Topics
- Strategies regarding REMS and singal detection to strenghten existing internal procedures
- Drug safety and risk management strategies
- Global regulations regarding drug safety and the proper reporting of adverse events
- Techniques to best protect the company from adverse events and ensure compliance if they do not occur
- Overcome challenges in post-marketing safety and in specific to clinical safety
Who should Attend
Directors, Vice Presidents and Managers within the biotechnology, pharmaceutical and medical device industries with responsibilies in Drug Safety/Risk Management, Pharmacovigilance, Drug/Product Safety, Pharmacoepidemiology, Chief Safety Officer, Clinical Safety, Signal Detection, Patient/Medical Safety, Safety Surveillance, REMS, Medical Director/Medical Affairs and Phase IV/Post-Marketing Studies.
